Skip to main content

Table 1 Characteristics of human study subjects

From: β2-agonists promote host defense against bacterial infection in primary human bronchial epithelial cells

 

Age

Sex

(M/F)

Smoking

(pack-years)

FEV1, %

predicted

FVC, %

predicted

FEV1/FVC%

Normal

(n = 8)

52.3 ± 4.3

4/4

4 - 0

4 - 37.0 ± 4.1

97.5 ± 6.8

92.0 ± 6.9

82.8 ± 1.3

COPD

(n = 8)

66.8 ± 1.8

3/5

8 - 67.8 ± 10.8

38.5 ± 7.7

61.4 ± 7.9

46.6 ± 6.7

Asthma

(n = 8)

48.8 ± 7.5

4/4

5 - 0

3 - 17.7 ± 6.7

82.1 ± 9.3

91.5 ± 8.0

69.5 ± 4.5

  1. FEV1, forced expiratory volume in the 1st second; FVC, forced vital capacity.